Incorporated in 2018, 23 Century International Life Science Centre is a clinical-stage biopharmaceutical company engaged in the discovery, research, development and commercialization of regenerative medicine in stem cell therapy.

23 Century focuses on developing regenerative medicine in treating refractory diseases that allow the human body to self-renew, repair, regenerate and to recreate functional tissues within its natural capacity.